Cronos Group Inc. Files Q1 2024 10-Q
Ticker: CRON · Form: 10-Q · Filed: 2024-05-09T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, cannabis, financials
TL;DR
Cronos Group Q1 2024 10-Q filed. Financials updated.
AI Summary
Cronos Group Inc. filed its 10-Q for the period ending March 31, 2024. The filing covers the first quarter of 2024 and provides financial details for the company. Key financial data and operational updates are presented for the reporting period.
Why It Matters
This filing provides investors with the latest financial performance and operational status of Cronos Group Inc. for the first quarter of 2024, crucial for investment decisions.
Risk Assessment
Risk Level: medium — As a cannabis company, Cronos Group operates in a highly regulated and evolving industry, which presents inherent risks.
Key Numbers
- 2024 Q1 — Reporting Period (First quarter of 2024)
- 1231 — Fiscal Year End (Company's fiscal year ends on December 31st)
Key Players & Entities
- Cronos Group Inc. (company) — Filer of the 10-Q
- 20240331 (date) — End of the reporting period
- 20240509 (date) — Filing date
- PharmaCan Capital Corp. (company) — Former company name
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2024.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 9, 2024.
What was Cronos Group Inc.'s former company name?
Cronos Group Inc.'s former company name was PharmaCan Capital Corp.
What is the Standard Industrial Classification code for Cronos Group Inc.?
The Standard Industrial Classification code for Cronos Group Inc. is 2833, which corresponds to MEDICINAL CHEMICALS & BOTANICAL PRODUCTS.
What is the fiscal year end for Cronos Group Inc.?
The fiscal year end for Cronos Group Inc. is December 31.
From the Filing
0001656472-24-000063.txt : 20240509 0001656472-24-000063.hdr.sgml : 20240509 20240509073235 ACCESSION NUMBER: 0001656472-24-000063 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 74 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240509 DATE AS OF CHANGE: 20240509 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cronos Group Inc. CENTRAL INDEX KEY: 0001656472 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38403 FILM NUMBER: 24928593 BUSINESS ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 BUSINESS PHONE: (416) 504-0004 MAIL ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 FORMER COMPANY: FORMER CONFORMED NAME: PharmaCan Capital Corp. DATE OF NAME CHANGE: 20151021 10-Q 1 cron-20240331.htm 10-Q cron-20240331 false 2024 Q1 0001656472 --12-31 P3Y P3Y P3Y xbrli:shares iso4217:USD iso4217:USD xbrli:shares cron:segment xbrli:pure iso4217:CAD iso4217:ILS iso4217:CAD xbrli:shares cron:shareholder cron:complaint cron:defendant 0001656472 2024-01-01 2024-03-31 0001656472 2024-05-06 0001656472 2024-03-31 0001656472 2023-12-31 0001656472 2023-01-01 2023-03-31 0001656472 us-gaap:CommonStockMember 2023-12-31 0001656472 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001656472 us-gaap:RetainedEarningsMember 2023-12-31 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001656472 us-gaap:NoncontrollingInterestMember 2023-12-31 0001656472 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001656472 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001656472 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001656472 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001656472 us-gaap:CommonStockMember 2024-03-31 0001656472 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001656472 us-gaap:RetainedEarningsMember 2024-03-31 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001656472 us-gaap:NoncontrollingInterestMember 2024-03-31 0001656472 us-gaap:CommonStockMember 2022-12-31 0001656472 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001656472 us-gaap:RetainedEarningsMember 2022-12-31 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001656472 us-gaap:NoncontrollingInterestMember 2022-12-31 0001656472 2022-12-31 0001656472 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001656472 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001656472 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001656472 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001656472 us-gaap:CommonStockMember 2023-03-31 0001656472 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001656472 us-gaap:RetainedEarningsMember 2023-03-31 0001656472 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001656472 us-gaap:NoncontrollingInterestMember 2023-03-31 0001656472 2023-03-31 0001656472 2023-04-01 2023-06-30 0001656472 cron:CannabisFlowerMember 2024-01-01 2024-03-31 0001656472 cron:CannabisFlowerMember 2023-01-01 2023-03-31 0001656472 cron:CannabisExtractsMember 2024-01-01 2024-03-31 0001656472 cron:CannabisExtractsMember 2023-01-01 2023-03-31 0001656472 us-gaap:ProductAndServiceOtherMember 2024-01-01 2024-03-31 0001656472 us-gaap:ProductAndServiceOtherMember 2023-01-01 2023-03-31 0001656472 country:CA 2024-01-01 2024-03-31 0001656472 country:CA 2023-01-01 2023-03-31 0001656472 country:IL 2024-01-01 2024-03-31 0001656472 country:IL 2023-01-01 2023-03-31 0001656472 2023-01-01 2023-12-31 0001656472 us-gaap:CreditConcentrationRiskMember cron:TwoCustomersMember us-gaap:AccountsRecei